Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study

BACKGROUND: Whether neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS) against primary debulking surgery (PDS) has a differential effect on prognosis due to Breast Cancer Susceptibility Genes (BRCA)1/2 mutations has not been confirmed by current studies. METHODS: All patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Mengdi, Jin, Chengjuan, Feng, Shuai, Jia, Zongyang, Nie, Lekai, Zhang, Yang, Peng, Jin, Wang, Xia, Bu, Hualei, Kong, Beihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770324/
https://www.ncbi.nlm.nih.gov/pubmed/35071013
http://dx.doi.org/10.3389/fonc.2021.810099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770324/
https://www.ncbi.nlm.nih.gov/pubmed/35071013
http://dx.doi.org/10.3389/fonc.2021.810099

Ejemplares similares